These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3609698)

  • 1. Ontogenesis of autonomic receptors and AChE activity in the rat vas deferens.
    Miranda HF; Wolstenholme WW; Moreu GM; Santiago PA
    Gen Pharmacol; 1987; 18(4):425-9. PubMed ID: 3609698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of alpha-adrenergic receptors in denervation supersensitivity of rat vas deferens.
    Hata F; Takeyasu K; Morikawa Y; Lai RT; Ishida H; Yoshida H
    Jpn J Pharmacol; 1981 Jun; 31(3):383-90. PubMed ID: 6273628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental changes in alpha-adrenergic and muscarinic receptor-mediated contractions of rat vas deferens.
    Higuchi H; Takeyasu K; Watanabe Y; Uchida S; Yoshida H
    Jpn J Pharmacol; 1982 Aug; 32(4):671-8. PubMed ID: 6290726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of haloperidol on neurotransmitter activity in the rat vas deferens.
    Miranda HF; Wolstenholme WW; Moreu GM; Santiago PA
    Gen Pharmacol; 1988; 19(1):123-7. PubMed ID: 2894332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed actions of hemicholinium at autonomic receptor sites of the rat vas deferens.
    Miranda HF; Santacana GE; Wolstenholme WW; Moreu GM
    Gen Pharmacol; 1987; 18(6):643-5. PubMed ID: 3666401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of brucine, a plant alkaloid, on M(1) muscarinic receptors and alpha(1)-adrenoceptors in the rabbit vas deferens preparation.
    Bradley KN; Rowan EG; Harvey AL
    Toxicon; 2001 Apr; 39(4):581-7. PubMed ID: 11024498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in response and number of alpha-adrenoceptors of rat vas deferens on brief pretreatment with an alpha-agonist.
    Hata F; Takeyasu K; Uchida S; Yoshida H
    Eur J Pharmacol; 1980 Oct; 67(2-3):193-9. PubMed ID: 6109634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
    Davies RH; Scholes HE; Virdi S; Broadley KJ
    J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens.
    Minneman KP; Fox AW; Abel PW
    Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective antagonism by pirenzepine and N-methyl-scopolamine on muscarinic receptor subtypes of the rat vas deferens.
    Miranda HF; Silva WI; Wolstenholme WW; Cuevas N
    Gen Pharmacol; 1988; 19(3):417-20. PubMed ID: 3417103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
    Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
    Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High spatial resolution studies of muscarinic neuroeffector junctions in mouse isolated vas deferens.
    Cuprian-Beltechi AM; Solanki P; Teramoto N; Cunnane TC
    Neuroscience; 2009 Sep; 162(4):1366-76. PubMed ID: 19486927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for pharmacological similarity between alpha 2-adrenoceptors in the vas deferens and central nervous system of the rat.
    Doxey JC; Gadie B; Lane AC; Tulloch IF
    Br J Pharmacol; 1983 Sep; 80(1):155-61. PubMed ID: 6140052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity profile of the novel muscarinic antagonist, guanylpirenzepine.
    Micheletti R; Schiavone A; Angelici O; Duranti P; Giudici L; Cereda E; Donetti A
    Life Sci; 1990; 47(15):PL55-8. PubMed ID: 2233131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of aging on alpha-adrenoceptors in rat heart and vas deferens.
    Lai R; Watanabe Y; Yoshida H
    Jpn J Pharmacol; 1983 Feb; 33(1):241-5. PubMed ID: 6308316
    [No Abstract]   [Full Text] [Related]  

  • 16. M1 and M2-muscarinic receptors in the epididymal half of the rat vas deferens.
    Doggrell SA
    Gen Pharmacol; 1986; 17(2):239-41. PubMed ID: 3754524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes-induced alterations in the properties of muscarinic cholinergic receptors in rat vas deferens.
    Kamai T; Fukumoto Y; Gousse A; Yoshida M; Davenport TA; Weiss RM; Latifpour J
    J Urol; 1994 Sep; 152(3):1017-21. PubMed ID: 8051725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding.
    Chang RS; Lotti VJ
    Life Sci; 1983 May; 32(22):2603-9. PubMed ID: 6134224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic denervation does not alter the density or properties of alpha-1 adrenergic receptors in rat vas deferens.
    Abel PW; Johnson RD; Martin TJ; Minneman KP
    J Pharmacol Exp Ther; 1985 Jun; 233(3):570-7. PubMed ID: 2989488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.